InvestorsHub Logo

SkyLimit2022

05/11/24 3:46 PM

#690704 RE: Nemesis18 #690701

Nemesis18,

I ran your post through an AI bs detector, and it was identified as bs
.



“The statement by Nemesis18 about the NICE appraisal of DCVAX-L is not only speculative and unfounded but also a clear example of disinformation designed to manipulate perceptions unfairly. Here are the key issues:

1. **Unfounded Assertions:** The claim that NICE's Health Economist will outright reject DCVAX-L is irresponsible and misleading. NICE decisions are based on a rigorous evaluation of all available evidence, including clinical and economic data, not on conjecture or preemptive judgments.

2. **Misrepresentation of Process:** Suggesting a "stated 87% failure rate" misrepresents how NICE assesses treatments. NICE uses detailed health economic analysis and clinical effectiveness data in their evaluations. Decisions are made after thorough consideration, not based on arbitrary or misrepresented statistics.

3. **Inaccurate Role Description:** The role of NICE and its health economists is grossly oversimplified in the statement. Their goal is to ensure treatments are both effective and cost-effective, without being influenced by external financial concerns of the biotech companies.

4. **Speculative and Misleading Tone:** The tone and content aim to provoke unwarranted fear and uncertainty about DCVAX-L's review process, which is typical of "short and distort" tactics where misinformation is spread to manipulate stock prices.

**Advisory:

**Beware of 'Short and Distort' Tactics:** Be cautious of speculative and unfounded statements designed to manipulate perceptions. These tactics are often used in attempts to influence stock prices by spreading negative rumors.

**Rely on Trustworthy Sources:** For accurate and reliable information about DCVAX-L and its regulatory status, consult peer-reviewed medical journals, official NICE documentation, and other authoritative sources like regulatory announcements.

By relying on credible, peer-reviewed sources and official statements, you can avoid being misled by reckless and harmful disinformation that seeks to distort the truth for speculative gain.

For the most accurate and reliable information, refer to the official NICE website (https://www.nice.org.uk/guidance/indevelopment/gid-ta10143) and trusted medical publications accessible through databases like https://pubmed.ncbi.nlm.nih.gov/


https://www.nature.com/articles/s41467-024-48073-y

https://www.jci.org/articles/view/169314

https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
Bullish
Bullish

martyDg

05/11/24 4:03 PM

#690708 RE: Nemesis18 #690701

Is this a joke? If they get MAA approval then NICE will have no choice but to give an appraisal.

kabunushi

05/11/24 8:29 PM

#690758 RE: Nemesis18 #690701

13% success rate is nonsense, a lie. Please just stop it. You get worked up over your laser-like focus on the wrong things. Like citing an 87% failure rate because only 13% of patients survive 5 years. First, all the patients under the glioblastoma death sentence are not throw-aways if they don't reach 5-year survival. Patients facing a 12-month death sentence getting another 12-24 months or even 6-12 months of high QoL with their families is not a failure in the least. Don't be stone-hearted and oblivious!

Furthermore, most recent studies have shown as many as 50% or more patients surviving more than 5 years with dc-vaxl in combination with other treatments. This is not part of the ph3 trial data but it's well known fact Fortunately, the RAs don't think like you! Your '87% failure rate' is a very big lie that reveals where you are coming from, and it's nowhere nice.

Second, NWBO's balance sheet is far from fantastic, but they have survived for several decades with no product income and there is no sign that they cannot deliver the treatment at a reasonable price per the market for similar treatments and become quite profitable just from the GBM patient population of the UK. Only the most closed-minded bean-counter would insist otherwise.

biosectinvestor

05/11/24 11:03 PM

#690772 RE: Nemesis18 #690701

This is a ridiculous and literally idiotic demonstration of your inability to understand cancer treatments and their successes. That you could even write this demonstrates such incredible ignorance it is not worth rebutting.

Worse still, you know it too. It's a sadistic taunting of retail longs who don't understand your literal sadism for being here. You're literally sick. Mentally ill. You know I know and I have got your number.
Bullish
Bullish